Thermo Fisher Scientific is the world leader in serving science. We offer leading next-generation sequencing (NGS) solutions for the study of myeloid and lymphoid malignancy samples. Our portfolio of assays enable a range of applications, including genomic profiling and clonality detection. Using our latest platform, you can have sequencing results in as fast as 1 day. To learn how you can see us during the meeting visit: www.oncomine.com/ash2022